Champions Oncology (CSBR) Receivables (2016 - 2025)
Historic Receivables for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to $19.7 million.
- Champions Oncology's Receivables rose 881.66% to $19.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $19.7 million, marking a year-over-year increase of 881.66%. This contributed to the annual value of $16.6 million for FY2025, which is 99.0% down from last year.
- As of Q4 2025, Champions Oncology's Receivables stood at $19.7 million, which was up 881.66% from $14.8 million recorded in Q3 2025.
- In the past 5 years, Champions Oncology's Receivables ranged from a high of $22.6 million in Q1 2025 and a low of $9.6 million during Q1 2021
- For the 5-year period, Champions Oncology's Receivables averaged around $14.1 million, with its median value being $13.3 million (2022).
- Per our database at Business Quant, Champions Oncology's Receivables crashed by 1212.08% in 2023 and then skyrocketed by 8370.67% in 2025.
- Champions Oncology's Receivables (Quarter) stood at $12.2 million in 2021, then increased by 9.32% to $13.3 million in 2022, then decreased by 12.12% to $11.7 million in 2023, then soared by 54.89% to $18.1 million in 2024, then increased by 8.82% to $19.7 million in 2025.
- Its Receivables was $19.7 million in Q4 2025, compared to $14.8 million in Q3 2025 and $16.6 million in Q2 2025.